The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s breast cancer diagnostics market report forecasts the breast cancer diagnostics market size to grow to $5.86 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Breast Cancer Diagnostics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report

Breast Cancer Diagnostics Market Size Forecast
The global breast cancer diagnostics market is expected to grow from $4.06 billion in 2022 to $4.4 billion in 2023 at a compound annual growth rate (CAGR) of 8.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The breast cancer diagnostics market is expected to grow from $5.86 billion in 2027 at a CAGR of 7.4%.

North America held the largest breast cancer diagnostics market share.

Key Breast Cancer Diagnostics Market Driver ­– Increase In The Incidence Of Breast Cancer
According to the World Health Organization (WHO), around 2.3 million women were diagnosed with breast cancer and 685,000 people died of breast cancer in 2020. Therefore, the increasing incidence of breast cancer is expected to drive the growth of the breast cancer diagnostics market.

Request for A Sample Of The Global Breast Cancer Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp

Key Breast Cancer Diagnostics Market Trend – Technological Advancement
Several new techniques have been developed which could be used in the diagnosis and treatment of breast cancer. The 3D mammography, also known as breast tomosynthesis, takes photographs around the breast from various angles and translates them into a 3-D model. In September 2022, Niramai, an Indian Health-Tech company, launched an innovative solution called Thermalytix. It is a automated breast cancer screening and diagnostic tool which combines thermal imaging and AI.

Breast Cancer Diagnostics Market Segment
1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types
2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies
3) By Cancer Type: BRCA Breast Cancer, ER & PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Other Cancer Types
4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies
5) By End Users: Hospitals and Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers

Breast Cancer Diagnostics Market Major Players and Strategies
Major players in the breast cancer diagnostics market are Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Siemens AG, NanoString Technologies Inc., and C.R. Bard Inc.

In January 2021, Hologic, a US-based women’s health medtech company, acquired Somatex Medical for $64 million. The acquisition would support Hologic’s strategy to provide comprehensive solutions for breast health care. Somatex is a German-based provider of Breast cancer diagnostic services.

The Breast Cancer Diagnostics Global Market Report 2023 covers regional data on breast cancer diagnostics market size, breast cancer diagnostics market trends and drivers, opportunities, strategies, and breast cancer diagnostics market competitor analysis. The countries covered in the breast cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Breast cancer is characterised by uncontrolled growth of cells in the breast, causing lumps. The breast cancer diagnostic devices are used to diagnose cancer that occurs in the breasts.

View More Reports Related To The Breast Cancer Diagnostics Market –
Breast Cancer Drugs Global Market Report 2023
Cancer Diagnostics Global Market Report 2023
Breast Cancer Monoclonal Antibodies Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: